Published in Multidiscip Respir Med on September 03, 2014
Computed tomography measurement of pulmonary artery for diagnosis of COPD and its comorbidity pulmonary hypertension. Int J Chron Obstruct Pulmon Dis (2015) 0.81
Recommendations for the early diagnosis of COPD: the AIMAR view. Multidiscip Respir Med (2015) 0.81
Development and the initial validation of a new self-administered questionnaire for an early detection of health status changes in smokers at risk for chronic obstructive pulmonary disease (MARKO questionnaire). Croat Med J (2016) 0.76
Most Italians attending a congress on health of elderly people do not know and do not recognize respiratory diseases. Multidiscip Respir Med (2016) 0.75
Early detection of COPD patients in GOLD 0 population: an observational non-interventional cohort study - MARKO study. BMC Pulm Med (2017) 0.75
Standards of suitability for the management of chronic obstructive respiratory diseases. Multidiscip Respir Med (2014) 0.75
What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Standardisation of spirometry. Eur Respir J (2005) 48.20
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2007) 47.86
Interpretative strategies for lung function tests. Eur Respir J (2005) 21.50
The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med (2004) 18.60
Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study. Lancet (1997) 7.29
Global burden of COPD: systematic review and meta-analysis. Eur Respir J (2006) 7.00
American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med (2006) 5.65
Illness trajectories and palliative care. BMJ (2005) 5.19
Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest (2007) 5.01
Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis. BMJ (2009) 4.28
An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med (2008) 3.98
Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest (2002) 3.82
Self-management education for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2007) 3.74
Interpreting COPD prevalence estimates: what is the true burden of disease? Chest (2003) 2.78
Risk factors for chronic obstructive pulmonary disease in a European cohort of young adults. Am J Respir Crit Care Med (2010) 2.66
Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med (2010) 2.60
Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax (2006) 2.46
The feasibility of smoking reduction: an update. Addiction (2005) 2.44
Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2011) 2.38
Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. BMJ (2002) 2.35
Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J Exp Med (2004) 2.19
Population impact of different definitions of airway obstruction. Eur Respir J (2003) 2.11
Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. J Am Geriatr Soc (2000) 2.09
Systematic review of the chronic care model in chronic obstructive pulmonary disease prevention and management. Arch Intern Med (2007) 2.06
Telehealthcare for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2011) 2.02
Diagnosis of airflow limitation combined with smoking cessation advice increases stop-smoking rate. Chest (2003) 1.99
Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med (2005) 1.89
Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review. Respir Med (2011) 1.89
Epidemiology of chronic obstructive pulmonary disease: a literature review. Int J Chron Obstruct Pulmon Dis (2012) 1.87
Reduction versus abrupt cessation in smokers who want to quit. Cochrane Database Syst Rev (2012) 1.84
Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy. Eur Respir J (2007) 1.78
Scoring system and clinical application of COPD diagnostic questionnaires. Chest (2006) 1.66
Proactive integrated care improves quality of life in patients with COPD. Eur Respir J (2009) 1.61
Prevalence of airways obstruction in a general population: European Respiratory Society vs American Thoracic Society definition. Chest (2000) 1.60
Nutritional support in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Am J Clin Nutr (2012) 1.58
Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender, and smoking habits. Respiration (2005) 1.55
Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS). COPD (2008) 1.55
FEV1/FEV6 and FEV6 as an alternative for FEV1/FVC and FVC in the spirometric detection of airway obstruction and restriction. Chest (2005) 1.51
Improving adherence with inhaler therapy in COPD. Int J Chron Obstruct Pulmon Dis (2010) 1.39
The impact of repeated spirometry and smoking cessation advice on smokers with mild COPD. Scand J Prim Health Care (2006) 1.32
Chronic disease prevalence from Italian administrative databases in the VALORE project: a validation through comparison of population estimates with general practice databases and national survey. BMC Public Health (2013) 1.27
Action plans with limited patient education only for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2010) 1.25
Comparison of existing symptom-based questionnaires for identifying COPD in the general practice setting. Respirology (2005) 1.24
Questions for COPD diagnostic screening in a primary care setting. Respir Med (2005) 1.23
Seven-year cumulative incidence of COPD in an age-stratified general population sample. Chest (2006) 1.21
Early detection of COPD in primary care: screening by invitation of smokers aged 40 to 55 years. Br J Gen Pract (2004) 1.20
The Confronting COPD International Survey: patients hardly know they have COPD. Eur Respir J (2002) 1.20
Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes. Int J Chron Obstruct Pulmon Dis (2009) 1.19
Chronic respiratory symptoms, spirometry and knowledge of COPD among general population. Respir Med (2006) 1.17
Development of a population-based screening questionnaire for COPD. COPD (2005) 1.15
An algorithm for the identification of undiagnosed COPD cases using administrative claims data. J Manag Care Pharm (2006) 1.09
Smoking cessation and COPD. Eur Respir Rev (2013) 1.09
Practical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care setting. Int J Chron Obstruct Pulmon Dis (2012) 1.08
Early detection of COPD in general practice: patient or practice managed? A randomised controlled trial of two strategies in different socioeconomic environments. Prim Care Respir J (2013) 1.05
How patients understand depression associated with chronic physical disease--a systematic review. BMC Fam Pract (2012) 1.04
Questionnaires and pocket spirometers provide an alternative approach for COPD screening in the general population. Chest (2012) 1.04
How to make sure your spirometry tests are of good quality. Respir Care (2003) 0.99
What we can say: disease illiteracy. J Assoc Physicians India (2011) 0.98
Long-term performance of a hand held spirometer. Thorax (1996) 0.98
The reality of drug use in COPD: the European perspective. Chest (2000) 0.97
The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden--the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study. Clin Respir J (2011) 0.96
Peak expiratory flow is not a quality indicator for spirometry: peak expiratory flow variability and FEV1 are poorly correlated in an elderly population. Chest (2007) 0.95
Focusing on outcomes: making the most of COPD interventions. Int J Chron Obstruct Pulmon Dis (2009) 0.94
Palliative care in COPD patients: is it only an end-of-life issue? Eur Respir Rev (2012) 0.91
End-of-life care for persons with advanced chronic obstructive pulmonary disease: report of a national interdisciplinary consensus meeting. Can Respir J (2009) 0.90
The use and abuse of office spirometry. Prim Care Respir J (2008) 0.90
Statement on home care for patients with respiratory disorders. Am J Respir Crit Care Med (2005) 0.87
Chronic critical illness: the growing challenge to health care. Respir Care (2012) 0.86
Hospital-at-home programs for patients with acute exacerbations of chronic obstructive pulmonary disease (COPD): an evidence-based analysis. Ont Health Technol Assess Ser (2012) 0.85
Health outcomes assessment and economic evaluation in COPD: challenges and opportunities. Eur Respir J Suppl (2003) 0.84
Definitions, causes, course, and prognosis of chronic obstructive pulmonary disease. Respir Care Clin N Am (1998) 0.83
ABC of chronic obstructive pulmonary disease. Primary care and palliative care. BMJ (2006) 0.82
The burden of COPD in France: results from the Confronting COPD survey. Respir Med (2003) 0.82
Provide GPs with spirometry, not spirometers. Thorax (2008) 0.81
Hand-held turbine spirometer: agreement with the conventional spirometer at baseline and after exercise. Pediatr Allergy Immunol (2005) 0.80
The effect of reducing the number of cigarettes smoked on risk of lung cancer, COPD, cardiovascular disease and FEV(1)--a review. Regul Toxicol Pharmacol (2013) 0.80
Standards of care and clinical predictors in patients hospitalised for a COPD exacerbation--the Italian SOS (Stratification Observational Study). Monaldi Arch Chest Dis (2009) 0.80
How should the lower limit of the normal range be defined? Respir Care (2012) 0.79
Accuracy and precision of desktop spirometers in general practices. Respiration (2012) 0.78
Spirometry: tool for pharmacy practitioners to expand direct patient care services. J Am Pharm Assoc (2003) (2013) 0.77
[Preventing cardiovascular diseases through a screening modelling applicable to wide population groups: results from the first phase of the project]. Epidemiol Prev (2014) 0.76
[Toward personalized and integrated treatment of patients with COPD]. Arch Bronconeumol (2010) 0.76
Underutilization of Spirometry for the Diagnosis of COPD. Chest (2008) 0.76
Accuracy and repeatability of a pocket turbine spirometer: comparison with a rolling seal flow-volume spirometer. Clin Physiol (1993) 0.76
General practice spirometry in North Staffordshire. Monaldi Arch Chest Dis (1999) 0.76
Risk of bacterial cross infection associated with inspiration through flow-based spirometers. Am J Infect Control (2011) 0.76
E-cigarettes, smokers and health policies. Monaldi Arch Chest Dis (2013) 0.75